MFB Fertility, the creator of a suite of at-home pregnancy-related hormone tests, announced a $9.7 million Series A round this week. The round follows several milestones for the company including an FDA premarket approval for a progesterone urine test and the rollout of a mobile app. It also gives the company more fodder to build […]...